GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » argenx SE (OTCPK:ARGNF) » Definitions » Fixed Maturity Investment

ARGNF (argenx SE) Fixed Maturity Investment


View and export this data going back to 2015. Start your Free Trial

What is argenx SE Fixed Maturity Investment?

Fixed Maturity Investment only applies to insurance companies.


argenx SE Business Description

Industry
Address
Laarderhoogtweg 25, Amsterdam, NH, NLD, 1101EB
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.